Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy

被引:88
作者
Heffernan, TM [1 ]
Jarvis, H
Rodgers, J
Scholey, AB
Ling, J
机构
[1] Northumbria Univ, Div Psychol, Human Cognit Neurosci Unit, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England
[2] Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Univ Teesside, Psychol Sect, Middlesbrough TS1 3BA, Cleveland, England
关键词
Ecstasy; MDMA; cannabis; prospective memory; central executive; cognitive failures;
D O I
10.1002/hup.349
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Chronic use of MDMA (3,4-methylenedioxymethamphetamine), or Ecstasy, is believed to lead to impaired psychological performance, including well-documented decrements in laboratory and field tests of retrospective memory. Less is known about the impact of Ecstasy on aspects of 'everyday' memory, despite obvious concerns about such effects. The three studies reported here focused on the impact of chronic Ecstasy use on prospective memory (PM), associated central executive function and other aspects of day-to-day cognition. In study 146 regular Ecstasy users were compared with 46 Ecstasy-free controls using the Prospective Memory Questionnaire (PMQ). Ecstasy users reported significantly more errors in PM (remembering to do something in the future); these findings persisted after controlling for other drug use and the number of strategies used to aid memory. No difference was found between representative subgroups on the Lies Scale of the Eysenck Personality Questionnaire. In study 2 a different group of 30 regular Ecstasy users and 37 Ecstasy-free controls was assessed on the PMQ and on a central executive task comprising verbal fluency measures. The results confirmed the significant impairments in long- and short-term PM and revealed corresponding impairments in verbal fluency. In study 315 Ecstasy users, 15 cannabis users and 15 non-drug users were assessed using the Cognitive Failures Questionnaire, which requires participants to provide ratings of the frequency of various day-to-day cognitive slips. The results indicate that the Ecstasy users did not perceive their general cognitive performance to be worse than that of controls. Taken together, these results suggest that Ecstasy users have impaired PM that cannot be explained by an increased propensity to exaggerate cognitive failures. These may be attributable, in pail, to central executive deficits that are due to frontal lobe damage associated with Ecstasy use. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:607 / 612
页数:6
相关论文
共 18 条
  • [1] THE COGNITIVE FAILURES QUESTIONNAIRE (CFQ) AND ITS CORRELATES
    BROADBENT, DE
    COOPER, PF
    FITZGERALD, P
    PARKES, KR
    [J]. BRITISH JOURNAL OF CLINICAL PSYCHOLOGY, 1982, 21 (FEB) : 1 - 16
  • [2] The relative contributions of ecstasy and cannabis to cognitive impairment
    Croft, RJ
    Mackay, AJ
    Mills, ATD
    Gruzelier, JGH
    [J]. PSYCHOPHARMACOLOGY, 2001, 153 (03) : 373 - 379
  • [3] Davison D, 1997, HUM PSYCHOPHARM CLIN, V12, P221
  • [4] Eysenck H.J., 1991, MANUAL EYSENCK PERSO
  • [5] Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)
    Gouzoulis-Mayfrank, E
    Daumann, J
    Tuchtenhagen, F
    Pelz, S
    Becker, S
    Kunert, HJ
    Fimm, B
    Sass, H
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 68 (06) : 719 - 725
  • [6] Effects of brain injury and age on prospective memory self-rating and performance
    Hannon, R
    Adams, P
    Harrington, S
    FriesDias, C
    Gipson, MT
    [J]. REHABILITATION PSYCHOLOGY, 1995, 40 (04) : 289 - 298
  • [7] Subjective ratings of prospective memory deficits in MDMA ('ecstasy') users
    Heffernan, TM
    Ling, J
    Scholey, AB
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2001, 16 (04) : 339 - 344
  • [8] Toxic effect of MDMA on brain serotonin neurons
    Klugman, A
    Hardy, S
    Baldeweg, T
    Gruzelier, J
    [J]. LANCET, 1999, 353 (9160) : 1269 - 1270
  • [9] KOPP UA, 2000, 1 INT C PROSP MEM U
  • [10] Characterization of a mutant T-cell hybridoma line with defects in the TCR-mediated apoptotic pathway
    Morgan, G
    Smith, S
    Pak, J
    Marshak-Rothstein, A
    Fissore, R
    Osborne, B
    [J]. CELL DEATH AND DIFFERENTIATION, 1999, 6 (01) : 36 - 47